Temporal arteritis epidemiology and demographics
|
Temporal Arteritis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Temporal arteritis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Temporal arteritis epidemiology and demographics |
|
Temporal arteritis epidemiology and demographics in the news |
|
Risk calculators and risk factors for Temporal arteritis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Incidence
- Incidence of GCA ranges from approximately 0.5 to 27 cases per 100,000 people aged 50 years or older.[1]
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- The incidence of temporal arteritis increases with age; the median age at diagnosis is 76.7 years.[2]
- Temporal arteritis commonly affects individuals older than 70 years of age.[3][4]
Race
- Temporal arteritis usually affects individuals of the white race. Black, Asians, and Hispanic individuals are less likely to develop temporal arteritis.[5][6]
Gender
- Women are more commonly affected by temporal arteritis than men. The female to male ratio is approximately 3 to 1.[5]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
- The highest incidence of temporal arteritis is reported in Scandanavian countries at 32.7 per 100,000 people for people over 50 years of age.[7]
References
- ↑ Goodwin JS (1992). "Progress in gerontology: polymyalgia rheumatica and temporal arteritis". J Am Geriatr Soc. 40 (5): 515–25. PMID 1634709.
- ↑ Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL; et al. (2010). "Increase in age at onset of giant cell arteritis: a population-based study". Ann Rheum Dis. 69 (4): 780–1. doi:10.1136/ard.2009.111005. PMID 19854712.
- ↑ Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE (2004). "Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period". Arthritis Rheum. 51 (2): 264–8. doi:10.1002/art.20227. PMID 15077270.
- ↑ Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A; et al. (2007). "Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study". Medicine (Baltimore). 86 (2): 61–8. doi:10.1097/md.0b013e31803d1764. PMID 17435586.
- ↑ 5.0 5.1 Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J; et al. (2009). "Epidemiology of giant cell arteritis and polymyalgia rheumatica". Arthritis Rheum. 61 (10): 1454–61. doi:10.1002/art.24459. PMID 19790127.
- ↑ Artal NM, Rodriguez M, Luna JD, Reviglio VE, Cuello O, Muiñ JC; et al. (2002). "Giant cell arteritis in a Hispanic population". Ophthalmology. 109 (10): 1757, discussion 1757. PMID 12359586.
- ↑ Smeeth, L (2006). "Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001". Annals of the Rheumatic Diseases. 65 (8): 1093–1098. doi:10.1136/ard.2005.046912. ISSN 0003-4967.